Genentech, Inc., is an American biotechnology corporation headquartered in South San Francisco, California. It became an independent subsidiary of Roche in 2009. Genentech Research and Early Development operates as an independent center and subsidiary within Roche.It has its own executive leadership team. Historically, the company is regarded as the world's first biotechnology company. As of July 2021, Genentech employed 13,539 people. The company was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Herbert Boyer. Boyer is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of interest from one source, to be ligated into a similarly cut plasmid vector. While Cohen returned to the laboratory in academia, Swanson contacted Boyer to found the company. Boyer worked with Arthur Riggs and Keiichi Itakura from the Beckman Research Institute, and the group became the first to successfully express a human gene in bacteria when they produced the hormone somatostatin in 1977. David Goeddel and Dennis Kleid were then added to the group, and contributed to its success with synthetic human insulin in 1978. More information...
According to PR-model, gene.com is ranked 62,789th in multilingual Wikipedia, in particular this website is ranked 46,861st in English Wikipedia.
The website is placed before kaesewelten.info and after bce.fin.ec in the BestRef global ranking of the most important sources of Wikipedia.
